We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
%{topic} RSS Feed RSS

FDA_Logo_Blue_2016.gif

FDA Says No Evidence NSAIDs Aggravate COVID-19 Symptoms

March 23, 2020
The Medicines and Healthcare Products Regulatory Agency also said Friday that there is currently no research linking ibuprofen to the likelihood of contracting the virus or worsening the symptoms. Read More

Lucence Working on Coronavirus Sample Collection Device

March 20, 2020
Ideally, samples should be transported in a chilled medium, but this is not always possible. Read More

Rheonix Seeks Emergency Authorization for COVID-19 Test

March 20, 2020
The cartridge-based system reduces sample handling time. Read More
Package front door

Carbon Health Ships Home COVID-19 Tests to California Patients

March 20, 2020
The kits should reduce the strain on clinics and prevent non-infected individuals from exposing themselves to the virus, the company said. Read More

Qiagen Snags CE Mark for Coronavirus Diagnostic

March 19, 2020
The multiplex nucleic acid test is the first syndromic testing solution cleared in the EU, the company said. Read More
Stop Hand Light

FDA Suspends Domestic Inspections as Coronavirus Outbreak Spreads

March 19, 2020
All eligible FDA employees are now teleworking. Read More
abbott-logo.gif

Abbott’s Coronavirus Test Earns Emergency Clearance

March 19, 2020
Abbott will distribute 150,000 tests immediately and aims to provide up to one million tests per week. Read More

Emergent BioSolutions to Develop Two COVID-19 Treatments

March 19, 2020
COVID-EIG will use plasma of immunized horses with antibodies to the virus as a potential treatment for severe hospitalized patients. Read More

Becton Dickinson, BioGX Seek FDA Emergency Clearance for COVID-19 Tests

March 18, 2020
The tests would increase the potential capacity to screen for COVID-19 by thousands of tests per day, BD said. Read More
COVID-19 TEST

FDA Clears Two More Coronavirus Diagnostics for Emergency Use

March 17, 2020
More than 90 diagnostic developers have contacted the FDA seeking guidance on coronavirus test development and validation, the agency said. Read More

European Commission to Fund Diagnostics Research to Tackle COVID-19

March 16, 2020
“As cases continue to rise, public health is the number one priority,” said the commission’s President Ursula von der Leyen. Read More

FDA Gives Go-Ahead for New York to Begin Testing for Coronavirus

March 13, 2020
Labs authorized by NYSDOH, “will not engage with FDA to begin patient testing,” said FDA Commissioner Stephen Hahn. Read More
Previous 1 2 … 103 104 105 106 107 108 109 110 111 Next

Upcoming Events

  • 21Jan

    Virtual MDSAP Audits in the Era of COVID-19: What to Know and Do to Pass Virtual Audits

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 27Jan

    FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations

  • 09Feb

    Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19

  • 10Feb

    FDA Under the Biden Administration: What’s to Come and What It Will Mean

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • COVID-19  Clinical Trial

    Synairgen Initiates Dosing in Late-Stage Trial of Inhaled COVID-19 Therapy

  • Verona Pharma logo

    Verona Pharma Ends Enrollment in Inhaler-Administered COVID-19 Drug Pilot

  • Purple_Approved_Stamp.gif

    Seno Medical Gets Premarket Approval for Breast Cancer Diagnostic

  • Triple Vaccine, needles

    Moderna to Start New Trial Adding Third Shot of COVID-19 Vaccine

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing